Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.02.034
Abstract: Univ Fed Sao Paulo, Escola Paulista Med, Rua Napoleao Barros 715, BR-04024002 Sao Paulo, Brazil read more here.
Keywords: novel p2y12; delayed onset; onset novel; receptor antagonists ... See more keywords
Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1721773
Abstract: Reduced pharmacodynamic (PD) effects of irreversible oral P2Y12 receptor antagonists have been reported when administered during cangrelor infusion. Therefore, the PD interaction liability of the novel P2Y12 receptor antagonist selatogrel with irreversible (i.e., clopidogrel, prasugrel)… read more here.
Keywords: ticagrelor; clopidogrel prasugrel; novel p2y12; selatogrel ... See more keywords